James Trager
Chief Tech/Sci/R&D Officer bei NKARTA, INC.
Vermögen: 2 Mio $ am 31.03.2024
Profil
James Trager is currently the Chief Scientific Officer at Nkarta, Inc. He previously worked at Dendreon Corp.
as the Senior Vice President-Research & Development from 2003 to 2019.
Trager holds a doctorate degree from the University of California, Berkeley and an undergraduate degree from St. John's College.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
NKARTA, INC.
0,20% | 12.02.2024 | 149 415 ( 0,20% ) | 2 Mio $ | 31.03.2024 |
Aktive Positionen von James Trager
| Unternehmen | Position | Beginn |
|---|---|---|
| NKARTA, INC. | Chief Tech/Sci/R&D Officer | 01.09.2016 |
Ehemalige bekannte Positionen von James Trager
| Unternehmen | Position | Ende |
|---|---|---|
| DENDREON CORPORATION | Chief Tech/Sci/R&D Officer | 01.12.2019 |
Ausbildung von James Trager
| University of California, Berkeley | Doctorate Degree |
| St. John's College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| NKARTA, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Dendreon Corp.
 Dendreon Corp. Medical SpecialtiesHealth Technology Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA. | Health Technology |
